Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Sep 03, 2024 4:38pm
224 Views
Post# 36206882

RE:New Investments

RE:New Investments
Bigkahuna57 wrote: I can't figure out why/how Health Canada has not become involved with huge grants.  The potential to avoid catastrophy and significant human suffering is overwhelming. 

Propose a license agreement with HC for avian flu development. The poultry industry produces more than 800 million dozen eggs annually.  Turkey and chicken production is over 1.5 Billion kilos annually. There are more than 2,000 registered chicken farms and over 500 turkey farms in Canada. Ontario and Quebec both have near, or over 600 chicken farms. Sell the potential to avoid a clear catastrophy and show some public investment to protect the food supply.

Roger, please approach the appropriate government agency that regulates poultry.  

IMO.

GLTA. Regards, BK.



Completely agree...

The ubiquitous transferrin receptor is not only utilized as a revolving door to bring iron into cells, it is currently being hijacked by the influenza virus, which includes the avian flu, to gain entry into host cells & begin its infection cycle.  As Dr. Mandel stated, an agent that competes for/blocks this receptor can open a new door or strategy for the prevention & treatment of various types of viral infection.  Current therapies function primarily by inhibiting DNA replication...after the cells are already infected.

So, this mechanism of action not only adresses the potential threat of an avian flu, but it has the potential to target the "current" yearly/seasonal threats/costs of influenza A and B.  It has been estimated (per Flu.gov) that there is ~$7 Billion in lost productivity annually in the US alone.  The CDC has estimated that seasonal flu outbreaks cost the US economy > $10 Billion in direct costs of hospitalizations & outpatient visits.  

On a federal level, you would think there should be little resistance to a licensing agreement...& HC may be the best start.  All imo...




<< Previous
Bullboard Posts
Next >>